Skip to content

Drug interactions

Dihydroergotamine + Eslicarbazepine

Severity: Moderate

Dihydroergotamine and Eslicarbazepine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine may decrease dihydroergotamine concentrations by inducing CYP3A4. The result is likely reduced migraine efficacy; the interaction is not expected to cause ergotism.

What this interaction means in plain words

Dihydroergotamine and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dihydroergotamine belongs to Central Nervous System; Eslicarbazepine belongs to Central Nervous System.

Evidence level: Low

Why it happens

CYP3A4 induction by eslicarbazepine increases dihydroergotamine clearance.

What to do

Monitor for reduced antimigraine response and consider alternative acute treatment if effect is lost.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine and Eslicarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine with Eslicarbazepine?

MediHelp rates the interaction as moderate. Dihydroergotamine and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eslicarbazepine may decrease dihydroergotamine concentrations by inducing CYP3A4. The result is likely reduced migraine efficacy; the interaction is not expected to cause ergotism.

How serious is the interaction between Dihydroergotamine and Eslicarbazepine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced antimigraine response and consider alternative acute treatment if effect is lost.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in